LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT04027946 · TERMINATED
Trial details
- NCT number
- NCT04027946
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-11
- Primary completion
- 2020-06-17
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.